States Split on New Rules for Mental Health Chatbots

New state limits on mental-health chatbots push firms like Teladoc and Headspace to boost safety and transparency; plan adaptive, compliant rollout strategies

4 Dec 2025

US states are moving at different speeds to regulate mental health and companion chatbots, creating a fragmented policy landscape that digital care companies are increasingly forced to navigate.

The tools, which offer emotional check-ins and basic guidance for users without easy access to clinicians, have expanded quickly. Their growth has raised concerns about where the line lies between informal support and regulated clinical care, and what obligations apply when automated systems fail to detect or escalate risks.

California has introduced SB 243, requiring companion tools used in health settings to make their nonhuman status clear and to report certain safety concerns to the state. Illinois has taken a stricter approach, prohibiting systems from presenting themselves as therapists or providing therapy without human supervision. Utah legislators are considering similar themes, but no firm proposals have been finalised. The result is a mosaic of rules rather than a national standard.

Underlying these efforts is a shared concern that rapid innovation could outpace public expectations on accuracy and accountability. Industry executives argue that clearer guardrails, even demanding ones, can support trust and reduce long-term regulatory uncertainty.

Companies including Teladoc and Headspace are already adjusting their operations. They are refining prompts, preparing state specific deployment plans and testing hybrid models that combine automated support with clinical review. Investors note potential growth for businesses that can comply with new requirements while maintaining product development.

Startups face greater pressure as they track evolving proposals across multiple jurisdictions with limited staff and budgets. Some founders say that well-designed regulation could help distinguish durable models from speculative ventures and encourage new partnerships.

As more states examine policy options, providers anticipate further divergence before any convergence emerges. Firms developing health focused AI tools are preparing for an environment in which innovation must be matched by careful compliance across state lines.